{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:26:38Z","timestamp":1791033998277,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/bf00686409","type":"journal-article","created":{"date-parts":[[2004,11,28]],"date-time":"2004-11-28T17:06:37Z","timestamp":1101661597000},"page":"152-154","source":"Crossref","is-referenced-by-count":21,"title":["Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro"],"prefix":"10.1007","volume":"30","author":[{"given":"Kathryn","family":"Osann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis M.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/bjc.1990.234","volume":"62","author":"HJ Broxterman","year":"1990","unstructured":"Broxterman HJ, Pinedo HM, Schurhuis GJ, Lankelma JL (1990) Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumor cells. Br J Cancer 62:85","journal-title":"Br J Cancer"},{"key":"CR2","first-page":"2953","volume":"50","author":"XF Hu","year":"1990","unstructured":"Hu XF, Martin TJ, Bell DR, deLuise M, Zalcberg JR (1990) Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res 50:2953","journal-title":"Cancer Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1349-7006.1990.tb02653.x","volume":"81","author":"Y Ishida","year":"1990","unstructured":"Ishida Y, Shimada Y, Shimoyama M (1990) Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells. Jpn J Cancer Res 81:834","journal-title":"Jpn J Cancer Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0304-3835(90)90033-T","volume":"54","author":"R Larrson","year":"1990","unstructured":"Larrson R, Nygren P (1990) Verapamil and cyclosporin A potentiate the effects of chemotherapeutic drugs in the human medullary thyroid carcinoma TT cell line not expressing the 170 kDa P glycoprotein. Cancer Lett 54:125","journal-title":"Cancer Lett"},{"key":"CR5","first-page":"567","volume":"4","author":"R Larrson","year":"1990","unstructured":"Larrson R, Nygren P, Ekberg M, Slater L (1990) Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay. Leukemia 4:567","journal-title":"Leukemia"},{"key":"CR6","first-page":"1749","volume":"51","author":"BL Samuels","year":"1990","unstructured":"Samuels BL, Ratain MJ (1990) Letter to the editor. Cancer Res 51:1749","journal-title":"Cancer Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0304-3835(91)90159-F","volume":"57","author":"Y Shoji","year":"1991","unstructured":"Shoji Y, Fisher MH, Priasamy A, Herman B, Juliano RL (1991) Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanisms. Cancer Lett 57:209","journal-title":"Cancer Lett"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1172\/JCI110702","volume":"70","author":"LM Slater","year":"1982","unstructured":"Slater LM, Murray SL, Wetzel MW, Wisdom RM, DuVall EM (1982) Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma. J Clin Invest 70: 1131?1134","journal-title":"J Clin Invest"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00255285","volume":"16","author":"LM Slater","year":"1986","unstructured":"Slater LM, Murray SL, Wetzel MW, Sweet P, Stupecky M (1986) Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance. Cancer Chemother Pharmacol 16:50","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI112450","volume":"77","author":"LM Slater","year":"1986","unstructured":"Slater LM, Sweet P, Stupecky M, Gupta S (1986) Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro. J Clin Invest 77:1405","journal-title":"J Clin Invest"},{"key":"CR11","first-page":"359","volume":"31","author":"LM Slater","year":"1990","unstructured":"Slater LM, Wetzel M, Cho J, Sweet P (1990) Cyclosporin A (CsA) enhancement of VP-16 and production of immunity to L1210 leukemia. Proc Am Assoc Cancer Res 31:359","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0360-3016(79)90634-5","volume":"5","author":"GG Steel","year":"1979","unstructured":"Steel GG (1979) Terminology in the description of drug-radiation interactions. Int J Radiat Oncol Biol Phys 5: 1145","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0360-3016(79)90044-0","volume":"5","author":"GG Steel","year":"1979","unstructured":"Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5:85","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"CR14","first-page":"1967","volume":"41","author":"T Tsuruo","year":"1981","unstructured":"Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967","journal-title":"Cancer Res"},{"key":"CR15","first-page":"4199","volume":"50","author":"DM Woodcock","year":"1990","unstructured":"Woodcock DM, Jefferson S, Linsenmeyer ME, Crowther PJ, Chojnowski GM, Williams B, Bertoncello I (1990) Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water insoluble vitamins and drugs. Cancer Res 50:4199?4203","journal-title":"Cancer Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00686409\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T10:10:54Z","timestamp":1554459054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00686409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992]]}},"alternative-id":["BF00686409"],"URL":"https:\/\/doi.org\/10.1007\/bf00686409","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992]]}}}